Globavir Biosciences Inc. — Form D/A
Globavir Biosciences Inc. of LOS ALTOS, CA, a company, filed a Form D amendment with the SEC on 2015-11-10. The offering totals $10.0M, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-11-10
- Form: D/A
- Accession: 0001144204-15-064085
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $10.0M
- Amount sold: $150K
- Remaining: $9.9M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2015-09-25
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-248799
Issuer
- Name: Globavir Biosciences Inc.
- CIK: 0001632042
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 5150 EL CAMINO REAL, LOS ALTOS, CA, 94022
- Phone: 650-384-0642
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Shalabh Gupta | Director | Los Altos, CA |
| Sandeep Laumas | Director | Greenwich, CT |
| John Ryan | Director | Coeur d'Alene, ID |
| Gilad Gordon | Executive Officer | Los Altos, CA |
| Shalabh Gupta | Executive Officer | Los Altos, CA |
| George Jue | Executive Officer | Los Altos, CA |
Other filings by this issuer (1)
More